The 2026 annual ENTIS conference has begun. This year the meeting is being held in Leiden, NL. The ENTIS board express their warm thanks to Miranda van Tuyl and all her colleagues from Lareb TIS who have organised the meeting venue and developed an engaging scientific programme. More details about the conference are available on the website.
» Read more
A message from the conference organiser Miranda van Tuyl (Teratology Information Service Lareb): In just over two weeks, the annual ENTIS Meeting 2026 will begin, and we are very much looking forward to welcoming you to Leiden! If you have not yet registered, there is still time to join us. You can register here. For those who have already registered, […]
» Read more
A collaboration of researchers and clinical experts, led by the REALIFE Research Group at the Research Unit Woman and Child, Department of Development and Regeneration, KU Leuven in Belgium, have published a review and set of clinical guidelines about GLP-1 and GIP medication use in pregnancy and breastfeeding. A link to the Pubmed index here, and the article shared by […]
» Read more
Researchers affiliated with the Swiss Teratology Information Service (Lausanne, Switzerland) have published a study examining the prevalence and patterns of use for IBD medications in the national MAMA cohort (health insurance claims data). More information is available here. Photo by MART PRODUCTION on PEXELS.
» Read more
ENTIS member Laure Sillis will defend her PhD thesis “Real-World Data to Evaluate Medication Safety in Pregnancy” on Thursday, June 4th 2026 at 17:00 (CET) in Leuven, Belgium. The defence will also be accessible via livestream. The thesis explores how different real-world data sources – from self-reported pregnancy registry data to large-scale administrative healthcare databases – can be used to […]
» Read more
ENTIS and Lareb (the local organizing committee of this years conference) are delighted to share some exciting news—the programme for the 2026 ENTIS meeting has now been published! You can find all the information about sessions and topics here. Keep an eye out, as details about the oral presenters will be added soon too. If you are planning to attend […]
» Read more
ENTIS associate members PhD candidate Laure Sillis and Dr Michael Ceulemans, alongside colleagues from KU Leuven, have published a study comparing self-reported maternal health and mother-infant outcomes in the BELpREG registry with medical record data from gynaecologists, general practitioners, and midwives. More information is available here.
» Read more
ENTIS associate members PhD candidate Laure Sillis, Dr Essi Whaites Heinonen and Dr Michael Ceulemans, alongside OTIS colleagues from University of California San Diego La Jolla (California, USA), have published a study using the MotherToBaby cohort investigating the risk for adverse birth outcomes following maternal use of medicines for nausea and vomiting in pregnancy. More information is available here.
» Read more
ENTIS associate members PhD candidate Laure Sillis and Dr Michael Ceulemans, alongside colleagues from KU Leuven, have published an updated summary of the medication, vaccine and folic acid use data from the the BELpREG Cohort. More information is available here.
» Read more
Researchers from the ENTIS member organisation Netherlands Pharmacovigilance Centre Lareb have published a comparative cohort study using the Dutch Pregnancy Drug Register to assess the risk of adverse neonatal outcomes following maternal pertussis vaccination in pregnancy. More information is available here. Photo by Alexander Grey on Unsplash
» Read more